Miguel Garcia, n/a

Technophage, Investigação e Desenvolvimento em Biotecnologia S.A., Portugal

Disclosure(s): IBV Innovation Bioventures Lda: Board Member, Ownership Interest; LX Bio Pharmaceuticals SA: Board Member, Ownership Interest; TechnoPhage, SA: Author of several patent applications, Board Member, Ownership Interest

Poster(s):

• 1690 - Assessing the safety of TP-102 bacteriophage treatment in the management of diabetic foot infections
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET